The Massachusetts General Hospital Harvard Center for Reproductive Medicine
马萨诸塞州总医院哈佛生殖医学中心
基本信息
- 批准号:10613357
- 负责人:
- 金额:$ 153.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-10 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAffectAgeArchitectureBiologicalBiological FactorsBiological ProcessBostonBrainCenter for Translational Science ActivitiesChildClinicalClinical ResearchClinical TreatmentCollectionCommunicationCommunitiesComputational BiologyCounselingCouplesCreativenessDNAData AnalyticsDenmarkDiagnosisDiseaseEducation and OutreachEndocrinologyEstoniaEthnic PopulationFacultyFamilyFertilityFinancial HardshipFinlandFosteringFutureGNRH1 geneGeneral HospitalsGenesGeneticGenetic EngineeringGenomicsGenotypeGoalsGonadal structureGroup MeetingsGynecologyHealthHospitalsHumanHuman DevelopmentHuman EngineeringHypogonadismIndividualInfertilityInformation DisseminationInstitutionInterdisciplinary StudyInternationalInvestigationInvestmentsKnowledgeLeadLeadershipLinkLongitudinal StudiesMassachusettsMendelian randomizationMentorsMentorshipMethodologyMethodsMorbidity - disease rateMutationNational Institute of Child Health and Human DevelopmentOperative Surgical ProceduresParentsPathway interactionsPatientsPediatricsPenetrancePhenotypePhysiologicalPopulationPopulation GeneticsPositioning AttributePreventionProviderPublic HealthRare DiseasesReproductionReproductive BiologyReproductive HealthReproductive MedicineResearchResearch PersonnelResearch Project GrantsResourcesRoleSamplingScientistServicesStrategic visionTechnologyTherapeuticThinkingTrainingTranslational ResearchUrologyValidationWorkbiobankclinical careclinical investigationclinical translationcohortcommunity engagementcomputerized toolscostdesignevidence baseflexibilityfunctional genomicsgene discoverygene functiongenetic architecturegenome editinggenome wide association studygenomic variationgonad developmenthuman diseaseimprovedinduced pluripotent stem cellinfertility treatmentinnovationlensliteracymembermortalitymulti-ethnicneuron developmentnext generationnext generation sequencingoutreachphenomephenomicspopulation basedpsychologicreproductivesexskillstargeted treatmenttraittranscriptomicstranslational scientistweb site
项目摘要
PROJECT ABSTRACT
Infertility affects up to 13% of reproductive age couples across the globe but the underlying mechanistic basis of
infertility and the role of infertility as an overall marker of general health is unclear. These knowledge gaps hinder
the diagnosis, treatment and prevention of infertility leading to physical, psychological and financial burden to
couples with infertility. To address these challenges, The Massachusetts General Hospital Harvard Center for
Reproductive Medicine has assembled an integrative team of investigators with expertise in reproductive
medicine, genomics, population genetics and genetic literacy who will conduct clinical translational investigation
in humans with infertility: Aim 1: To elucidate the genetic and phenomic architecture of infertility through the lens
of specific rare diseases and common traits; Aim 2: To catalyze a collaborative think-tank focused on reducing
the suffering and costs of infertility, in a manner that is outward looking, forward thinking and integrates global
perspectives; Aim 3: To nucleate a vibrant hub for outreach, training and community engagement that brings the
scientific team closer to the patients they serve, the trainees they want to mentor, and the larger community of
scientists and clinicians who are invested in reducing the burdens caused by infertility. These aims will be
achieved using two Clinical Research projects which will be supported by a Genomics and Functional Core,
Outreach Core and Administrative Core. Project 1 will perform next-generation sequencing and targeted
genotype-driven phenotyping studies in clinical cohorts enriched for genetically driven infertility from admixed
and consanguineous populations characterized by both hypogonadotropic and hypergonadotropic
hypogonadism in both sexes. Project 2 will bring together >1,800,000 multi-ethnic population biobank samples
to perform genome-wide association studies, phenome-wide association studies, and Mendelian randomization
studies to implicate key biologic pathways determining fertility and synthesize the genetic results across infertility
and related traits to characterize the effects of the identified genes and pathways on reproductive health and
overall morbidity. The Genomics and Functional Core will provide genomic technologies, data analytics,
computational and statistical support, and will generate genetically engineered human induced pluripotent cells
for validation of Project 1 & 2 genetic discoveries. The Outreach Core will buoy Project 1 & 2 activities by
engaging key stakeholders through patient group meetings, creating clinician-facing materials to enable
communication of genetic results and launch a website inspired by design-thinking for broad dissemination to
patients, families and clinicians. The Administrative Core will advance the Center’s scientific goals by providing
timely support to foster engagement and communication between investigators, patients, research trainees and
the broader academic community. Through these interdigitating activities, the Center will train the next
generation of reproductive biologists and the results emanating from its activities will help inform clinical care
and alleviate the suffering of patients with infertility.
项目摘要
不孕症影响了地球仪上多达13%的育龄夫妇,但不孕症的潜在机制基础是,
不孕症和不孕症作为一般健康的总体标志的作用尚不清楚。这些知识差距阻碍了
诊断、治疗和预防不孕导致的身体、心理和经济负担,
不孕不育的夫妇为了应对这些挑战,马萨诸塞州总医院哈佛中心
生殖医学组建了一支由具有生殖专业知识的研究人员组成的综合团队
医学,基因组学,群体遗传学和遗传素养,他们将进行临床转化研究
目的1:通过透镜阐明不孕症的遗传和表型结构
目标2:促进建立一个合作智囊团,重点是减少
不孕症的痛苦和代价,以一种外向的方式,前瞻性的思维和整合全球
目标3:成为一个充满活力的外联、培训和社区参与中心,
科学团队更接近他们所服务的患者,他们想要指导的学员,以及更大的社区,
科学家和临床医生致力于减轻不孕症造成的负担。这些目标将是
通过两个临床研究项目实现,该项目将得到基因组学和功能核心的支持,
外展核心和行政核心。项目1将进行下一代测序,
在临床队列中进行的基因型驱动的表型研究,
和具有低促性腺激素和高促性腺激素特征的近亲群体
两性性腺功能减退症。项目2将汇集超过180万个多族裔人口生物库样本
进行全基因组关联研究、全表型关联研究和孟德尔随机化
研究涉及决定生育力的关键生物途径,并综合不孕症的遗传结果
和相关性状,以表征所确定的基因和途径对生殖健康的影响,
总体发病率。基因组学和功能核心将提供基因组技术、数据分析,
计算和统计支持,并将产生基因工程人类诱导多能细胞
用于验证项目1和2的基因发现。外联核心将通过以下方式支持项目1和2的活动:
通过患者小组会议吸引关键利益相关者,创建面向临床医生的材料,
交流遗传结果,并推出一个受设计思维启发的网站,以广泛传播,
患者、家属和临床医生。行政核心将通过提供以下服务来推进中心的科学目标:
及时提供支持,以促进研究者、患者、研究学员之间的参与和沟通,
更广泛的学术界。通过这些相互交织的活动,该中心将培训下一个
生殖生物学家的产生及其活动产生的结果将有助于告知临床护理
减轻不孕症患者的痛苦。
项目成果
期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Racial and Ethnic Disparities in Genomic Healthcare Utilization, Patient Activation, and Intrafamilial Communication of Risk among Females Tested for BRCA Variants: A Mixed Methods Study.
- DOI:10.3390/genes14071450
- 发表时间:2023-07-15
- 期刊:
- 影响因子:3.5
- 作者:Hesse-Biber, Sharlene;Seven, Memnun;Shea, Hannah;Heaney, Madeline;Dwyer, Andrew A.
- 通讯作者:Dwyer, Andrew A.
Advancing qualitative rare disease research methodology: a comparison of virtual and in-person focus group formats.
- DOI:10.1186/s13023-022-02522-3
- 发表时间:2022-09-11
- 期刊:
- 影响因子:3.7
- 作者:Dwyer, Andrew A.;Uveges, Melissa;Dockray, Samantha;Smith, Neil
- 通讯作者:Smith, Neil
What Are the Best Practices for Co-Creating Patient-Facing Educational Materials? A Scoping Review of the Literature.
- DOI:10.3390/healthcare11192615
- 发表时间:2023-09-23
- 期刊:
- 影响因子:2.8
- 作者:McDonald, Isabella R.;Blocker, Elizabeth S.;Weyman, Elizabeth A.;Smith, Neil;Dwyer, Andrew A.
- 通讯作者:Dwyer, Andrew A.
Latinx individuals' knowledge of, preferences for, and experiences with prenatal genetic testing: a scoping review.
- DOI:10.1186/s12978-022-01438-2
- 发表时间:2022-06-06
- 期刊:
- 影响因子:3.4
- 作者:Grafft, Natalie;Dwyer, Andrew A.;Pineros-Leano, Maria
- 通讯作者:Pineros-Leano, Maria
Exploring Rare Disease Patient Attitudes and Beliefs regarding Genetic Testing: Implications for Person-Centered Care.
- DOI:10.3390/jpm12030477
- 发表时间:2022-03-16
- 期刊:
- 影响因子:0
- 作者:Dwyer AA;Uveges MK;Dockray S;Smith N
- 通讯作者:Smith N
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephanie Beth Seminara其他文献
Stephanie Beth Seminara的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephanie Beth Seminara', 18)}}的其他基金
Phase 2 Kp-10 in Patients with Hypogonadotropic Hypogonadism
低促性腺激素性性腺功能减退症患者的 2 期 Kp-10
- 批准号:
10730209 - 财政年份:2023
- 资助金额:
$ 153.33万 - 项目类别:
Project 1 - Deciphering the Molecular Drivers of Rare Forms of Human Infertility Using Integrative Genomic, Cellular, and Phenomic Approaches
项目 1 - 使用综合基因组、细胞和表型组方法破译罕见人类不孕症的分子驱动因素
- 批准号:
10463545 - 财政年份:2021
- 资助金额:
$ 153.33万 - 项目类别:
The Massachusetts General Hospital Harvard Center for Reproductive Medicine
马萨诸塞州总医院哈佛生殖医学中心
- 批准号:
10463543 - 财政年份:2021
- 资助金额:
$ 153.33万 - 项目类别:
Project 1 - Deciphering the Molecular Drivers of Rare Forms of Human Infertility Using Integrative Genomic, Cellular, and Phenomic Approaches
项目 1 - 使用综合基因组、细胞和表型组方法破译罕见人类不孕症的分子驱动因素
- 批准号:
10613359 - 财政年份:2021
- 资助金额:
$ 153.33万 - 项目类别:
Phase 2 Kp-10 for Dopamine Agonist Intolerant Hyperprolactinemia IND 74,977
多巴胺激动剂不耐受高催乳素血症 2 期 Kp-10 IND 74,977
- 批准号:
10116170 - 财政年份:2018
- 资助金额:
$ 153.33万 - 项目类别:
Kisspeptin and Neurokinin B: Physiology in Monkey to Pathophysiology in Human
Kisspeptin 和 Neurokinin B:从猴子的生理学到人类的病理生理学
- 批准号:
9431349 - 财政年份:2017
- 资助金额:
$ 153.33万 - 项目类别:
Kisspeptin Physiology in Human Reproduction
Kisspeptin 人类生殖生理学
- 批准号:
8190179 - 财政年份:2011
- 资助金额:
$ 153.33万 - 项目类别:
Kisspeptin Physiology in Human Reproduction
Kisspeptin 人类生殖生理学
- 批准号:
8334058 - 财政年份:2011
- 资助金额:
$ 153.33万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 153.33万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 153.33万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 153.33万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 153.33万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 153.33万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 153.33万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 153.33万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 153.33万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 153.33万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 153.33万 - 项目类别:
Research Grant